作者首先引用文献介绍1923年Levaditi报导了疫苗病毒,对Ehilich腹水肿瘤的溶瘤作用。1974年浅田用腮腺病毒治疗癌肿患者有效,除一过性的中等度发热外,无其他副作用。其机理可能为直接溶瘤,腮腺病毒系用Urabe株的疫苗,-70℃保存,使用前解冻,1日1次,3日一疗程。 The author first quoted the literature and introduced Levaditi in 1923 to report the oncolytic effect of the vaccine virus on Ehilich’s ascites tumors. In 1974, Asada was effective in treating cancer patients with scorpion adenovirus and had no other side effects except transient moderate fever. The mechanism may be direct oncolysis, and the vaccine for Urabe strains of salivary glands is stored at -70°C, thawed before use, once a day, and on a three-day course.